,
Pirson, F. A. V. ( Anne)
Hinsenveld, Wouter H.
Goldhoorn, Robert-Jan B.
Staals, Julie
de Ridder, Inger R.
van Zwam, Wim H.
van Walderveen, Marianne A. A.
Lycklama à Nijeholt, Geert J.
Uyttenboogaart, Maarten
Schonewille, Wouter J.
van der Lugt, Aad
Dippel, Diederik W. J.
Roos, Yvo B. W. E. M.
Majoie, Charles B. L. M.
van Oostenbrugge, Robert J.
Funding for this research was provided by:
Hartstichting
Hersenstichting
Article History
Received: 19 March 2020
Accepted: 2 February 2021
First Online: 24 February 2021
Ethics approval and consent to participate
: The medical ethical committee of the Erasmus University Medical Center in Rotterdam approved this study (MEC-2017-367). Written informed consent (deferred) for trial participation and their anonymized information to be published will be obtained from the patients or their legal representatives.
: Not applicable
: WvZ reports that Maastricht University Medical Center received compensation from Stryker® and Cerenovus® for consultations by WvZ. CM reports that Amsterdam UMC received research grants from CVON/Dutch Heart Foundation, European Commission, TWIN Foundation, and Stryker®; he is a shareholder of Nico-Lab.